Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Emergent BioSolutions Inc (NYSE:EBS)

40.45
Delayed Data
As of 1:20pm ET
 -0.12 / -0.30%
Today’s Change
24.47
Today|||52-Week Range
41.46
+23.17%
Year-to-Date

Today’s Trading

Previous close40.57
Today’s open40.50
Day’s range40.11 - 40.77
Volume86,179
Average volume (3 months)284,660
Market cap$1.7B
Dividend yield--
Data as of 1:20pm ET, 10/17/2017

Growth & Valuation

Earnings growth (last year)-19.86%
Earnings growth (this year)+0.49%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-6.50%
P/E ratio27.7
Price/Sales3.31
Price/Book2.76

Competitors

 Today’s
change
Today’s
% change
PCRXPacira Pharmaceutica...-0.65-1.88%
LXRXLexicon Pharmaceutic...+0.03+0.27%
INVAInnoviva Inc-0.04-0.29%
MYOKMyoKardia Inc-0.90-2.37%
Data as of 1:34pm ET, 10/17/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)$0.34
Annual revenue (last year)$488.8M
Annual profit (last year)$51.8M
Net profit margin12.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel J. Abdun-Nabi
Executive VP-
Business Operations
Adam R. Havey
Corporate headquarters
Gaithersburg, Maryland

Forecasts